Brought to you by 
NuBiyota teams up with Takeda in new GI microbiome deal
21 Apr 2017
Executive Summary
Takeda Pharmaceutical Co. Ltd. signed its second microbiome deal in less than a week, this time partnering with NuBiyota LLC to discover and develop new therapies for undisclosed gastroenterology conditions.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com